Related Experiment Video
Updated: Feb 28, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Oxetane Substrates of Human Microsomal Epoxide Hydrolase
Francesca Toselli1, Marlene Fredenwall1, Peder Svensson1
1Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development, AstraZeneca, Mölndal, Sweden (F.T., M.F., X.-Q.L., A.J., L.W., M.A.H.); and Integrative Research Laboratories, Arvid Wallgrens Backe 20, Gothenburg, Sweden (P.S.).
Oxetane hydrolysis by human microsomal epoxide hydrolase (mEH) is a key metabolic pathway in drug development. Structural modifications near the oxetane ring significantly influence its breakdown rate, offering insights for designing new drugs.
Area of Science:
- Medicinal Chemistry
- Drug Metabolism
- Biocatalysis
Background:
- Oxetanyl building blocks enhance drug-like properties in drug candidates.
- Limited knowledge exists regarding the biotransformation of oxetanes.
Purpose of the Study:
- To investigate the biotransformation of oxetane-containing compounds.
- To identify the enzymes responsible for oxetane ring opening.
- To characterize the kinetics and structural determinants of oxetane hydrolysis.
Main Methods:
- Incubations with human liver fractions and hepatocytes.
- Use of inhibitors for cytochrome P450 (P450), microsomal epoxide hydrolase (mEH), and soluble epoxide hydrolase (sEH).
- Investigation of NADPH dependence in subcellular fractions.
- Kinetic characterization of oxetane hydrolysis in human liver microsomes and recombinant mEH.
Main Results:
- Direct evidence of oxetane hydrolysis by human recombinant microsomal epoxide hydrolase (mEH).
- mEH-mediated hydrolysis is the sole oxetane ring-opening metabolic route in human liver fractions and hepatocytes.
- No contribution from sEH or P450-catalyzed oxidation.
- Hydrolysis efficiency is modulated by structural elements near the oxetane, such as pKa, distance from benzylic nitrogen, and methyl group presence.
Conclusions:
- Oxetanes are identified as the first non-epoxide substrates for human mEH.
- Findings are valuable for developing biologically active oxetanes.
- Potential for biocatalytic generation of enantiomerically pure oxetanes and diols.
More Related Videos
Related Concept Videos
Preparation of Epoxides
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
Base-Catalyzed Ring-Opening of Epoxides
Acid-Catalyzed Ring-Opening of Epoxides
Structure and Nomenclature of Epoxides
Sharpless Epoxidation
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

